title: Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
authors.forename: J P
authors.initials: JP
authors.lastname: Gockerman
authors.forename: H
authors.initials: H
authors.lastname: Silberman
authors.forename: A A
authors.initials: AA
authors.lastname: Bartolucci
mesh_terms: D015250:Aclarubicin; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D009279:Naphthacenes / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000903:Antibiotics, Antineoplastic; D009279:Naphthacenes; D015250:Aclarubicin